Cell proliferation in colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers.
Cell renewal in the large intestine mucosa is normally tied to a rigidly compartmentalized model. Immunohistochemical identification of cells in S phase through uptake of bromodeoxyuridine is the method of choice for detailed compartmental mapping of proliferation, while immunohistochemical detection of proliferation-associated antigens (Ki-67, PCNA, DNA polymerase alpha) provides information in advanced tumor cases. Mucosal hyperproliferation due to inflammation may be transient (self-limited colitis, Crohn's disease, acute radiation damage) or lasting (ulcerative colitis). Progressive shifting of the proliferation zone to the crypt surface (Stage II abnormality) is a late feature of irradiated rectal mucosa and subgroups of ulcerative colitis patients at high risk for cancer. Hyperproliferation and Stage II abnormality coexist in the mucosa of patients with colorectal neoplasia, but are mutually independent and correlated to different clinical and pathological features of the disease. These cytokinetic abnormalities are highly predictive markers of the adenoma-carcinoma sequence, but are not associated with de novo adenocarcinoma. Proliferation increases progressively in the subsequent steps of this sequence, except in early cancer.
Risio
M
M
Department of Pathology, S. Giovanni Vecchio Hospital, Torino, Italy.
D000236:Adenoma / Q000473:pathology*; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis*; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000032:analysis*; D002277:Carcinoma / Q000473:pathology*; D002455:Cell Division; D003108:Colonic Diseases / Q000473:pathology; D003110:Colonic Neoplasms / Q000473:pathology* / Q000517:prevention & control; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation; D007413:Intestinal Mucosa / Q000473:pathology*; D009024:Morphogenesis; D011230:Precancerous Conditions / Q000473:pathology*; D012004:Rectal Neoplasms / Q000473:pathology* / Q000517:prevention & control
D000951:Antigens, Neoplasm; D015415:Biomarkers; D014408:Biomarkers, Tumor